Corcept Therapeutics News, Corcept Therapeutics Quote, CORT Quote

Corcept Therapeutics (NQ:CORT) Delayed: 22.48 -0.52 (2.26%)

Prev. Close

$23.00

Open

$23.00

52 Wk High

$10.00

52 Wk Low

$3.22

Day High

$23.29

Day Low

$22.05

P/E

N/A

EPS

$-0.46

Volume

1,087,749

Friends, Peers and Foes (?): TEVA (more...)

Apr 24, 2024 04:05 PM Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
Apr 22, 2024 08:00 AM Corcept Therapeutics (CORT) Reports Positive Results From Open-Label Portion of Phase 3 GRACE Trial
Apr 22, 2024 08:00 AM Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome
Apr 18, 2024 05:10 PM Form DEFA14A CORCEPT THERAPEUTICS
Apr 17, 2024 04:45 PM Form ARS CORCEPT THERAPEUTICS For: Dec 31
Apr 17, 2024 06:06 AM Form 8-K CORCEPT THERAPEUTICS For: Apr 12
Apr 15, 2024 08:07 AM Corcept Therapeutics (CORT) Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis
Apr 15, 2024 08:00 AM Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)
Apr 12, 2024 07:00 PM Form 4 CORCEPT THERAPEUTICS For: Apr 10 Filed by: MAHONEY DAVID L
Apr 10, 2024 04:44 PM Form DEF 14A CORCEPT THERAPEUTICS For: Apr 10

Entities mentioned with CORT